Lunai Bioworks (LNAI) Cash & Current Investments (2011 - 2026)

Lunai Bioworks' Cash & Current Investments history runs 16 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 93.19% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (up 93.19% YoY), while the FY2025 annual figure was $480551.0, up 117.97% from the prior year.
• Cash & Current Investments was $3.2 million for Q1 2026 at Lunai Bioworks, up from $491645.0 in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $11.2 million in Q1 2022 to a low of $220467.0 in Q2 2024.
• Historically, Cash & Current Investments has averaged $2.7 million across 5 years, with a median of $624808.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments sank 94.08% in 2023, then surged 422.32% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $4.1 million in 2022, then tumbled by 94.08% to $243980.0 in 2023, then climbed by 27.78% to $311764.0 in 2024, then jumped by 57.7% to $491645.0 in 2025, then jumped by 541.78% to $3.2 million in 2026.
• The last three Cash & Current Investments figures came in at $3.2 million (Q1 2026), $491645.0 (Q4 2025), and $624808.0 (Q3 2025), per Business Quant data.